Brazil to treat severe monkeypox cases with antiviral drug Tecovirimat

Xinhua News Agency

RIO DE JANEIRO — Brazil plans to use the antiviral drug Tecovirimat to treat severe cases of monkeypox, which has already claimed one life in the country, Health Minister Marcelo Queiroga said Monday, Aug. 1.

“The most serious cases will be taken into account first,” Queiroga said via Twitter, adding Brazil will receive the drug thanks to mediation by the Pan American Health Organization, but did not specify how many doses will be supplied.

Tecovirimat is being used as a “compassionate care” option in the United States. Its efficacy in combating monkeypox has yet to be proven.

On Friday, health officials confirmed the first monkeypox-related death in Brazil, involving a 41-year-old man whose case is still being investigated.

According to the latest data released by the Brazilian government, the South American country has detected at least 1,342 cases of the disease. – gb

Popular

PH passes 2027 ASEAN chairship to Singapore

By Dean Aubrey Caratiquet As the 49th ASEAN Summit drew to a close, President Ferdinand R. Marcos Jr. looked back at the priorities that the...

Trade, tourism take center stage at ASEAN-India Summit

By Dean Aubrey Caratiquet Moving beyond regional boundaries, ASEAN continues to build upon its relationship with India, which can create further opportunities for both parties. Spearheading...

ASEAN-Japan Summit focuses on energy, defense, cybersecurity, people-to-people exchanges

By Dean Aubrey Caratiquet Beyond building energy resiliency, the Philippines also expressed its interest to work with other member states in the areas of cybersecurity,...

Security, tech, trade among key highlights in ASEAN-ROK Summit

By Dean Aubrey Caratiquet Beyond culture and cuisine, South Korea’s contributions to the region continue to expand under the country’s partnership with the Association of...